Mark Yarchoan (@markyarchoan) 's Twitter Profile
Mark Yarchoan

@markyarchoan

Physician scientist @JohnsHopkins @hopkinskimmel @CMM_JHU, focused on translational immunotherapy research for #HCC, #cholangiocarcinoma

ID: 970073089903128576

calendar_today03-03-2018 23:07:02

602 Tweet

1,1K Followers

376 Following

Mark Yarchoan (@markyarchoan) 's Twitter Profile Photo
Mark Yarchoan
@markyarchoan

11 days ago

More disappointing news in #HCC: Adjuvant pembrolizumab failed to beat surveillance in the global P3 #KEYNOTE-937 trial (NCT03867084). Merck disclosed the negative result quietly in an SEC filing. Not unexpected after #IMbrave050

More disappointing news in #HCC: Adjuvant pembrolizumab failed to beat surveillance in the global P3 #KEYNOTE-937 trial (NCT03867084). Merck disclosed the negative result quietly in an SEC filing. Not unexpected after #IMbrave050